Cargando…
Immune imprinting as a barrier to effective COVID-19 vaccines
Wang and colleagues show that immune imprinting impairs neutralizing antibody titers for bivalent mRNA vaccination against SARS-CoV-2 Omicron subvariants. Imprinting from three doses of monovalent vaccine can be alleviated by BA.5 or BQ-lineage breakthrough infection but not by a bivalent booster.(1...
Autores principales: | Faraone, Julia N., Liu, Shan-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694758/ https://www.ncbi.nlm.nih.gov/pubmed/37992689 http://dx.doi.org/10.1016/j.xcrm.2023.101291 |
Ejemplares similares
-
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
por: Griffiths, Elizabeth A., et al.
Publicado: (2021) -
Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
por: Montefiori, David C.
Publicado: (2022) -
Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment
por: Lischer, Christopher, et al.
Publicado: (2023) -
COVID-19 and the differential dilemma
por: Climer, Sharlee
Publicado: (2021) -
Of variants and vaccines
por: Grubaugh, Nathan D., et al.
Publicado: (2021)